Impact of Directly Acting Antivirals (DAAs) Treatment on Rates of Hepatocellular Carcinoma (HCC) in Hepatitis C Virus (HCV) and HIV Co-infected Patients

被引:0
|
作者
Bari, Shahla [1 ]
Chan, Austin [1 ]
Olanipekun, Titilope [1 ]
Chawla, Saurabh [2 ]
机构
[1] Morehouse Sch Med, Atlanta, GA 30310 USA
[2] Emory Univ, Sch Med, Atlanta, GA USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
888
引用
收藏
页码:S493 / S494
页数:2
相关论文
共 50 条
  • [21] Hepatocellular carcinoma in hepatitis C virus patients treated with direct acting antivirals (DAAs) and patients not exposed to DAAs: a large center comparative study
    Elgazzar, Mohamed
    Salman, Tary
    Abdelsameea, Eman
    Akl, Mohamed
    Omar, Nabil
    Abdel-Samiee, Mohamed
    Abas, Shrif
    Elsakhawy, Mohmoud
    Elsherif, Ahmed
    Abdelkader, Ibrahim
    Elazab, Dina
    Ehsan, Nermine
    Mohamady, Mohamed
    El-Kassas, Mohamed
    Omar, Hazem Metwaly
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2024, 55 (01):
  • [22] Survival of HIV/HCV co-infected patients before introduction of HCV direct acting antivirals (DAA)
    Dold, L.
    Schwarze-Zander, C.
    Boesecke, C.
    Mohr, R.
    Langhans, B.
    Wasmuth, J-C
    Strassburg, C. P.
    Rockstroh, J. K.
    Spengler, U.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [23] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Tajiri, Kazuto
    Ito, Hiroyuki
    Kawai, Kengo
    Kashii, Yoshiro
    Hayashi, Yuka
    Murayama, Aiko
    Minemura, Masami
    Takahara, Terumi
    Shimizu, Yukihiro
    Yasuda, Ichiro
    WORLD JOURNAL OF HEPATOLOGY, 2022, 14 (06) : 1190 - 1199
  • [24] Impact of treatment with direct-acting antivirals on inflammatory markers and autoantibodies in HIV/HCV co-infected individuals
    Rossotti, Roberto
    Merli, Marco
    Baiguera, Chiara
    Bana, Nicholas Brian
    Rezzonico, Leonardo Francesco
    D'Amico, Federico
    Raimondi, Alessandro
    Moioli, Maria Cristina
    Chianura, Leonardo Gerolamo
    Puoti, Massimo
    JOURNAL OF VIRAL HEPATITIS, 2023, 30 (06) : 530 - 539
  • [25] Direct-acting antivirals for hepatitis C virus-infected patients with hepatocellular carcinoma
    Kazuto Tajiri
    Hiroyuki Ito
    Kengo Kawai
    Yoshiro Kashii
    Yuka Hayashi
    Aiko Murayama
    Masami Minemura
    Terumi Takahara
    Yukihiro Shimizu
    Ichiro Yasuda
    World Journal of Hepatology, 2022, 14 (06) : 1190 - 1199
  • [26] Hepatocellular carcinoma in patients co-infected with hepatitis C virus and human immunodeficiency virus
    Dimitrios Dimitroulis
    Serena Valsami
    Eleftherios Spartalis
    Emmanuel Pikoulis
    Gregory Kouraklis
    World Journal of Hepatology, 2013, (06) : 323 - 327
  • [27] Hepatitis C Direct-Acting Antiviral Agents in HIV/HCV Co-infected Patients
    Valérie Martel-Laferrière
    Douglas T. Dieterich
    Current Treatment Options in Infectious Diseases, 2014, 6 (2) : 132 - 143
  • [28] The Risk of Hepatocellular Carcinoma After Directly Acting Antivirals for Hepatitis C Virus Treatment in Liver Transplanted Patients: Is It Real?
    Strazzulla, Alessio
    Iemmolo, Rosa Maria Rita
    Carbone, Ennio
    Postorino, Maria Concetta
    Mazzitelli, Maria
    De Santis, Mario
    Di Benedetto, Fabrizio
    Cristiani, Costanza Maria
    Costa, Chiara
    Pisani, Vincenzo
    Torti, Carlo
    HEPATITIS MONTHLY, 2016, 16 (11)
  • [29] Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: "A Flood of Opportunity''
    Gane, E. J.
    Agarwal, K.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 (05) : 994 - 1002
  • [30] Directly active antivirals pharmacokinetics in HCV/HIV co-infected patients with advanced hepatic fibrosis
    Marinaro, L.
    Merli, M.
    Barco, A.
    Alcantarini, C.
    Montrucchio, C.
    Tettoni, M. C.
    Vendemiati, G.
    Bocchino, G.
    De Nicolo, A.
    Hasson, H.
    D'Avolio, A.
    Foppa, C. U.
    Di Perri, G.
    Bonora, S.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S534 - S534